Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Valdecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is a selective cyclooxygenase-2 inhibitor. It was patented in 1995.
Applications, Art, Regions & Companies
Explore the main themes, entities and connections around Valdecoxib. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
bextra pfizer drug fda arthritis company united states settlement largest billion 2005 market 2009 prescription american risk adverse fine anti-inflammatory
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Valdecoxib | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Valdecoxib | ATC code | M01AH03 (WHO) | 1.00 | infobox |
| Valdecoxib | Bioavailability | 83% | 1.00 | infobox |
| Valdecoxib | CAS Number | 181695-72-7 N | 1.00 | infobox |
| Valdecoxib | ChEBI | CHEBI:63634 N | 1.00 | infobox |
| Valdecoxib | ChEMBL | ChEMBL865 Y | 1.00 | infobox |
| Valdecoxib | ChemSpider | 106796 Y | 1.00 | infobox |
| Valdecoxib | CompTox Dashboard (EPA) | DTXSID6044226 | 1.00 | infobox |
| Valdecoxib | DrugBank | DB00580 Y | 1.00 | infobox |
| Valdecoxib | ECHA InfoCard | 100.229.918 | 1.00 | infobox |
| Valdecoxib | Elimination half-life | 8 to 11 hours | 1.00 | infobox |
| Valdecoxib | Excretion | Renal | 1.00 | infobox |
| Valdecoxib | Formula | C16H14N2O3S | 1.00 | infobox |
| Valdecoxib | IUPHAR/BPS | 2894 | 1.00 | infobox |
| Valdecoxib | KEGG | D02709 Y | 1.00 | infobox |
| Valdecoxib | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Valdecoxib | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Valdecoxib | Legal status | Withdrawn in U.S., EU, Canada and parts of Asia | 1.00 | infobox |
| Valdecoxib | Metabolism | Hepatic (CYP3A4 and 2C9 involved) | 1.00 | infobox |
| Valdecoxib | Molar mass | 314.36 g·mol−1 | 1.00 | infobox |
| Valdecoxib | Pregnancy category | AU: C | 1.00 | infobox |
| Valdecoxib | Pregnancy category | May cause premature closure of the ductus arteriosus | 1.00 | infobox |
| Valdecoxib | Protein binding | 98% | 1.00 | infobox |
| Valdecoxib | PubChem CID | 119607 | 1.00 | infobox |
| Valdecoxib | Routes of administration | Oral | 1.00 | infobox |
| Valdecoxib | Trade names | Bextra | 1.00 | infobox |
| Valdecoxib | UNII | 2919279Q3W | 1.00 | infobox |
| Valdecoxib | is a | nonsteroidal anti-inflammatory drug | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.